6. Hamberg, M., and B. Samuelsson. 1967. Oxygenation of unsatu-
rated fatty acids by the vesicular gland of sheep. J. Biol. Chem. 242:
5344–5354.
7. Xiao, G., A. L. Tsai, G. Palmer, W. C. Boyar, P. J. Marshall, and R. J.
Kulmacz. 1997. Analysis of hydroperoxide-induced tyrosyl radicals
and lipoxygenase activity in aspirin-treated human prostaglandin H
synthase-2. Biochemistry. 36: 1836–1845.
1982. Formation of leukotrienes and other hydroxy acids dur-
ing platelet-neutrophil interactions in vitro. Biochem. Biophys. Res.
Commun. 109: 130–137.
26. Dixon, R. A., R. E. Diehl, E. Opas, E. Rands, P. J. Vickers, J. F. Evans,
J. W. Gillard, and D. K. Miller. 1990. Requirement of a 5-lipoxy-
genase-activating protein for leukotriene synthesis. Nature. 343:
282–284.
8. Mancini, J. A., G. P. O’Neill, C. Bayly, and P. J. Vickers. 1994.
Mutation of serine-516 in human prostaglandin G/H synthase-2
to methionine or aspirin acetylation of this residue stimulates
15-R-HETE synthesis. FEBS Lett. 342: 33–37.
9. Holtzman, M. J., J. Turk, and L. P. Shornick. 1992. Identification of
a pharmacologically distinct prostaglandin H synthase in cultured
epithelial cells. J. Biol. Chem. 267: 21438–21445.
10. Lecomte, M., O. Laneuville, C. Ji, D. L. DeWitt, and W. L. Smith.
1994. Acetylation of human prostaglandin endoperoxide synthase-2
(cyclooxygenase-2) by aspirin. J. Biol. Chem. 269: 13207–13215.
11. Schneider, C., and A. R. Brash. 2000. Stereospecificity of hydrogen
abstraction in the conversion of arachidonic acid to 15R-HETE by
aspirin-treated cyclooxygenase-2. J. Biol. Chem. 275: 4743–4746.
12. Maas, R. L., J. Turk, J. A. Oates, and A. R. Brash. 1982. Formation
of a novel dihydroxy acid from arachidonic acid by lipoxygenase-
catalyzed double oxygenation in rat mononuclear cells and human
leukocytes. J. Biol. Chem. 257: 7056–7067.
13. Serhan, C. N., M. Hamberg, and B. Samuelsson. 1984. Lipoxins: novel
series of biologically active compounds formed from arachidonic
acid in human leukocytes. Proc. Natl. Acad. Sci. USA. 81: 5335–5339.
14. Kühn, H., R. Wiesner, L. Alder, B. J. Fitzsimmons, J. Rokach, and
A. R. Brash. 1987. Formation of lipoxin B by the pure reticulocyte
lipoxygenase via sequential oxygenation of the substrate. Eur. J.
Biochem. 169: 593–601.
15. Clària, J., and C. N. Serhan. 1995. Aspirin triggers previously unde-
scribed bioactive eicosanoids by human endothelial cell-leukocyte
interactions. Proc. Natl. Acad. Sci. USA. 92: 9475–9479.
16. Mulugeta, S., T. Suzuki, N. Tejera Hernandez, M. Griesser, W. E.
Boeglin, and C. Schneider. 2010. Identification and absolute con-
figuration of dihydroxy-arachidonic acids formed by oxygenation
of 5S-HETE by native and aspirin-acetylated COX-2. J. Lipid Res. 51:
575–585.
17. Schneider, C., W. E. Boeglin, H. Yin, D. F. Stec, and M. Voehler.
2006. Convergent oxygenation of arachidonic acid by 5-lipoxyge-
nase and cyclooxygenase-2. J. Am. Chem. Soc. 128: 720–721.
18. Bailey, J. M., R. W. Bryant, J. Whiting, and K. Salata. 1983.
Characterization of 11-HETE and 15-HETE, together with prosta-
cyclin, as major products of the cyclooxygenase pathway in cultured
rat aorta smooth muscle cells. J. Lipid Res. 24: 1419–1428.
19. Setty, B. N., M. J. Stuart, and R. W. Walenga. 1985. Formation of
11-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic
acid in human umbilical arteries is catalyzed by cyclooxygenase.
Biochim. Biophys. Acta. 833: 484–494.
27. Bozza, P. T., P. Pacheco, W. Yu, and P. F. Weller. 2002. NS-398:
cyclooxygenase-2 independent inhibition of leukocyte priming
for lipid body formation and enhanced leukotriene generation.
Prostaglandins Leukot. Essent. Fatty Acids. 67: 237–244.
28. Schneider, C., W. E. Boeglin, and A. R. Brash. 2000. Enantiomeric
separation of hydroxy-eicosanoids by chiral column chromatogra-
phy: effect of the alcohol modifier. Anal. Biochem. 287: 186–189.
29. Petrich, K., P. Ludwig, H. Kuhn, and T. Schewe. 1996. The sup-
pression of 5-lipoxygenation of arachidonic acid in human
polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-
hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity re-
lationship and mechanism of action. Biochem. J. 314: 911–916.
30. Setty, B. N., and M. J. Stuart. 1986. 15-Hydroxy-5,8,11,13-eicosatetraenoic
acid inhibits human vascular cyclooxygenase. Potential role in diabetic
vascular disease. J. Clin. Invest. 77: 202–211.
31. Folco, G., and R. C. Murphy. 2006. Eicosanoid transcellular bio-
synthesis: from cell-cell interactions to in vivo tissue responses.
Pharmacol. Rev. 58: 375–388.
32. Griesser, M., T. Suzuki, N. Tejera, S. Mont, W. E. Boeglin, A. Pozzi,
and C. Schneider. 2011. Biosynthesis of hemiketal eicosanoids by
cross-over of the 5-lipoxygenase and cyclooxygenase-2 pathways.
Proc. Natl. Acad. Sci. USA. 108: 6945–6950.
33. Turk, J., R. L. Maas, A. R. Brash, L. J. Roberts 2nd, and J. A. Oates.
1982. Arachidonic acid 15-lipoxygenase products from human eo-
sinophils. J. Biol. Chem. 257: 7068–7076.
34. Chavis, C., P. Chanez, I. Vachier, J. Bousquet, F. B. Michel, and P.
Godard. 1995. 5–15-diHETE and lipoxins generated by neutrophils
from endogenous arachidonic acid as asthma biomarkers. Biochem.
Biophys. Res. Commun. 207: 273–279.
35. Patrignani, P., M. R. Panara, A. Greco, O. Fusco, C. Natoli, S.
Iacobelli, F. Cipollone, A. Ganci, C. Creminon, J. Maclouf, et al.
1994. Biochemical and pharmacological characterization of the cy-
clooxygenase activity of human blood prostaglandin endoperoxide
synthases. J. Pharmacol. Exp. Ther. 271: 1705–1712.
36. Borgeat, P., and B. Samuelsson. 1979. Arachidonic acid metabolism
in polymorphonuclear leukocytes: effects of ionophore A23187.
Proc. Natl. Acad. Sci. USA. 76: 2148–2152.
37. Schneider, C., D. A. Pratt, N. A. Porter, and A. R. Brash. 2007.
Control of oxygenation in lipoxygenase and cyclooxygenase cataly-
sis. Chem. Biol. 14: 473–488.
38. Vanderhoek, J. Y., R. W. Bryant, and J. M. Bailey. 1980. Inhibition
of leukotriene biosynthesis by the leukocyte product 15-hydroxy-
5,8,11,13-eicosatetraenoic acid. J. Biol. Chem. 255: 10064–10066.
39. Ueda, N., S. Kaneko, T. Yoshimoto, and S. Yamamoto. 1986.
Purification of arachidonate 5-lipoxygenase from porcine leuko-
cytes and its reactivity with hydroperoxyeicosatetraenoic acids. J.
Biol. Chem. 261: 7982–7988.
20. Griesser, M., W. E. Boeglin, T. Suzuki, and C. Schneider. 2009.
Convergence of the 5-LOX and COX-2 pathways. Heme-catalyzed
cleavage of the 5S-HETE-derived di-endoperoxide into aldehyde
fragments. J. Lipid Res. 50: 2455–2462.
21. Schneider, C., Z. Yu, W. E. Boeglin, Y. Zheng, and A. R. Brash.
2007. Enantiomeric separation of hydroxy and hydroperoxy eico-
sanoids by chiral column chromatography. Methods Enzymol. 433:
145–157.
22. Brash, A. R., and W-C. Song. 1996. Detection, assay, and isolation of
allene oxide synthase. Methods Enzymol. 272: 250–259.
23. Lee, S. H., M. V. Williams, R. N. DuBois, and I. A. Blair. 2003.
Targeted lipidomics using electron capture atmospheric pres-
sure chemical ionization mass spectrometry. Rapid Commun. Mass
Spectrom. 17: 2168–2176.
24. Borgeat, P., and B. Samuelsson. 1979. Metabolism of arachidonic
acid in polymorphonuclear leukocytes. Structural analysis of novel
hydroxylated compounds. J. Biol. Chem. 254: 7865–7869.
25. Marcus, A. J., M. J. Broekman, L. B. Safier, H. L. Ullman, N. Islam,
C. N. Sherhan, L. E. Rutherford, H. M. Korchak, and G. Weissmann.
40. Mancini, J. A., H. Waterman, and D. Riendeau. 1998. Cellular
oxygenation of 12-hydroxyeicosatetraenoic acid and 15-hydroxyei-
cosatetraenoic acid by 5-lipoxygenase is stimulated by 5-lipoxyge-
nase-activating protein. J. Biol. Chem. 273: 32842–32847.
41. O’Flaherty, J. T., and M. J. Thomas. 1985. Effect of 15-lipoxygenase-
derived arachidonate metabolites on human neutrophil degranu-
lation. Prostaglandins Leukot. Med. 17: 199–212.
42. Morita, E., J. M. Schroder, and E. Christophers. 1990. Identification
of a novel and highly potent eosinophil chemotactic lipid in
human eosinophils treated with arachidonic acid. J. Immunol. 144:
1893–1900.
43. Schwenk, U., E. Morita, R. Engel, and J. M. Schroder. 1992.
Identification of 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid
as a novel and potent human eosinophil chemotactic eicosanoid.
J. Biol. Chem. 267: 12482–12488.
94
Journal of Lipid Research Volume 53, 2012